Nearly 80 percent of pharmaceutical manufacturing facilities are located outside of the United States. U.S. Representatives Abigail Spanberger, Angie Craig, and Jefferson Van Drew have introduced the bipartisan RAPID Reserve Act to incentivize American-based manufacturers to increase reserves of critical pharmaceutical ingredients and reduce the country's reliance on China for medications. The bill is supported by leading health organizations and has a companion bill in the Senate.
Frequently Asked Questions
Q: Who is leading the bipartisan effort to address critical medication shortages?
A: Abigail Spanberger is leading a bipartisan effort to address critical medication shortages and reduce American reliance on China. Source
Q: What is the main goal of the bipartisan effort mentioned?
A: The main goal of the bipartisan effort is two-fold: to address critical medication shortages within the United States and to reduce the American reliance on China for critical medications. Source
Q: What percentage of pharmaceuticals is related to the issue addressed by Spanberger’s initiative?
A: The specific percentage of pharmaceuticals related to the initiative is not mentioned in the provided links. For more detailed information, please visit Abigail Spanberger's official website or related congressional records.
Q: Are other members of Congress involved in this effort?
A: Yes, it is mentioned as a bipartisan effort, which indicates that other members of Congress, including those from both parties, are involved. Specific names beyond Spanberger, such as Rep. Angie Craig, are implied to be involved as indicated by their own news updates. Source
Q: Is there any legislation related to this effort?
A: The search results do not mention specific current legislation directly tied to Spanberger's effort. However, for information on legislation that may be related to pharmaceuticals and supply chains, you may review recent bills such as H.R.5376, the Inflation Reduction Act, or the CHIPS and Science Act (H.R.4346). To get updated legislative information, visit congress.gov.
Q: How significant is the reliance on China for medications?
A: Although no specific data is given in the search results, Spanberger's efforts suggest that reliance on China for critical medications is a significant concern for U.S. healthcare and national security, warranting legislative action. Source
Q: What is being done to combat drug shortages in the U.S.?
A: The effort led by Spanberger appears to be part of a broader set of activities to combat drug shortages, which may include legislative measures, increased domestic production, and diversified international supply chains. Specifics regarding measures can be reviewed in the context of individual bills such as the Consolidated Appropriations Act, H.R.2617. Source